» Articles » PMID: 38641669

Radiofrequency Ablation of Parathyroid Adenoma: Results of a Retrospective Analysis of 60 Patients

Overview
Date 2024 Apr 19
PMID 38641669
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To present the effectiveness and safety of radiofrequency ablation (RFA) in parathyroid adenoma (PTA).

Materials And Methods: In this retrospective study, 60 patients with a single PTA were evaluated for changes in biochemical and ultrasonographic features up to 6 months after RFA of the lesion. Adenomas were ablated with an alternative technique so called "Nik jet dissection" which incorporates full hydrodissection and polar artery coagulation. Complications as well as the variations in biochemical data and nodule volumes were analyzed between baseline measurements and at each follow-up interval data (first day, 1, 3, and 6 months after ablation) were analyzed.

Results: A significant reduction in serum intact parathyroid hormone and calcium levels was observed 6 months after ablation, with a mean difference of - 83.4 ± 104.1 pg/mL, p < 0.001, and - 0.29 ± 0.22 mmol/L, p < 0.001, respectively. Serum phosphorus levels increased significantly with a mean difference of 0.09 ± 0.19 mmol/L, p = 0.040 at the end of the follow up. We observed a significant volume reduction rate of parathyroid adenomas with 89 ± 20.8 percent, p < 0.001. Also, 51% of adenomas disappeared at the end of the follow up. In this study, two cases of hematoma and one case of transient hoarseness (grade 1 of the CIRSE classification) were encountered.

Conclusion: Our study showed that RFA with the alternative technique, called "Nik jet dissection" is a safe and effective modality in management of PTA. Therefore, we suggest expanding the indications for RFA in PTA management, especially when surgery is not feasible.

Level Of Evidence: Level 3, Local non-random sample.

Citing Articles

Successful Radiofrequency Ablation of an Intrathyroidal Parathyroid Adenoma After Failed Parathyroidectomy.

Eldeiry L, Faintuch S, Sacks B AACE Clin Case Rep. 2024; 10(6):253-256.

PMID: 39734504 PMC: 11680750. DOI: 10.1016/j.aace.2024.08.009.

References
1.
Chai H, Zhao Y, Zeng Z, Ye R, Hu Q, He H . Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism: A Prospective Study. Korean J Radiol. 2022; 23(5):555-565. PMC: 9081691. DOI: 10.3348/kjr.2021.0716. View

2.
Wei Y, Peng C, Wang S, He J, Peng L, Zhao Z . Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study. J Clin Endocrinol Metab. 2021; 106(9):2707-2717. PMC: 8372654. DOI: 10.1210/clinem/dgab240. View

3.
Ebrahiminik H, Chegeni H, Mosadegh Khah A, Salouti R, Ghomashchi G, Pasikhani M . Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: A report of 27 patients. J Clin Ultrasound. 2022; 50(4):540-546. DOI: 10.1002/jcu.23181. View

4.
Khandelwal A, Batra S, Jajodia S, Gupta S, Khandelwal R, Kapoor A . Radiofrequency Ablation of Parathyroid Adenomas: Safety and Efficacy in a Study of 10 Patients. Indian J Endocrinol Metab. 2021; 24(6):543-550. PMC: 7906106. DOI: 10.4103/ijem.IJEM_671_20. View

5.
Hansler J, Harsch I, Strobel D, Hahn E, Becker D . [Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA)]. Ultraschall Med. 2002; 23(3):202-6. DOI: 10.1055/s-2002-33154. View